BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12553472)

  • 1. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.
    Smith RK; Korda M; Blunn GW; Goodship AE
    Equine Vet J; 2003 Jan; 35(1):99-102. PubMed ID: 12553472
    [No Abstract]   [Full Text] [Related]  

  • 2. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study.
    Guest DJ; Smith MR; Allen WR
    Equine Vet J; 2008 Mar; 40(2):178-81. PubMed ID: 18267891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
    Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine mesenchymal stromal cells and embryo-derived stem cells are immune privileged in vitro.
    Paterson YZ; Rash N; Garvican ER; Paillot R; Guest DJ
    Stem Cell Res Ther; 2014 Jul; 5(4):90. PubMed ID: 25080326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis.
    Caniglia CJ; Schramme MC; Smith RK
    Equine Vet J; 2012 Sep; 44(5):587-93. PubMed ID: 22150794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon.
    Guest DJ; Smith MR; Allen WR
    Equine Vet J; 2010 Oct; 42(7):636-42. PubMed ID: 20840579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 'Can you regain your youth?'--the real potential of stem cell technology.
    Smith RK
    Equine Vet J; 2010 Jan; 42(1):2-4. PubMed ID: 20121905
    [No Abstract]   [Full Text] [Related]  

  • 8. A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses.
    Marfe G; Rotta G; De Martino L; Tafani M; Fiorito F; Di Stefano C; Polettini M; Ranalli M; Russo MA; Gambacurta A
    Life Sci; 2012 Jun; 90(21-22):825-30. PubMed ID: 22480518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon.
    Godwin EE; Young NJ; Dudhia J; Beamish IC; Smith RK
    Equine Vet J; 2012 Jan; 44(1):25-32. PubMed ID: 21615465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and Development Symposium: Stem cell therapy in equine tendon injury.
    Reed SA; Leahy ER
    J Anim Sci; 2013 Jan; 91(1):59-65. PubMed ID: 23100589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of autologous bone marrow-derived mesenchymal stem cells in naturally occurring tendinopathy.
    Smith RK; Werling NJ; Dakin SG; Alam R; Goodship AE; Dudhia J
    PLoS One; 2013; 8(9):e75697. PubMed ID: 24086616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of autologous adipose tissue-derived mesenchymal stem cells on neovascularization of artificial equine tendon lesions.
    Conze P; van Schie HT; van Weeren R; Staszyk C; Conrad S; Skutella T; Hopster K; Rohn K; Stadler P; Geburek F
    Regen Med; 2014; 9(6):743-57. PubMed ID: 25431911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal derived embryonic-like stem cells improve healing in a large animal flexor tendonitis model.
    Watts AE; Yeager AE; Kopyov OV; Nixon AJ
    Stem Cell Res Ther; 2011 Jan; 2(1):4. PubMed ID: 21272343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory considerations related to stem cell treatment in horses.
    Yingling GL; Nobert KM
    J Am Vet Med Assoc; 2008 Jun; 232(11):1657-61. PubMed ID: 18518806
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
    Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
    Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tendon injuries and their treatment in the horse.
    McCullagh KG; Goodship AE; Silver IA
    Vet Rec; 1979 Jul; 105(3):54-7. PubMed ID: 400209
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell therapy for tendon repair in horses: an experimental study.
    Crovace A; Lacitignola L; De Siena R; Rossi G; Francioso E
    Vet Res Commun; 2007 Aug; 31 Suppl 1():281-3. PubMed ID: 17682895
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study.
    Bosch G; van Schie HT; de Groot MW; Cadby JA; van de Lest CH; Barneveld A; van Weeren PR
    J Orthop Res; 2010 Feb; 28(2):211-7. PubMed ID: 19714688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does firing have a valid place in the treatment of superficial digital flexor tendon injury in the 21st century?
    Marr CM; Bowen IM
    Equine Vet J; 2012 Sep; 44(5):509-10. PubMed ID: 22888772
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of single intralesional treatment of surgically induced equine superficial digital flexor tendon core lesions with adipose-derived mesenchymal stromal cells: a controlled experimental trial.
    Geburek F; Roggel F; van Schie HTM; Beineke A; Estrada R; Weber K; Hellige M; Rohn K; Jagodzinski M; Welke B; Hurschler C; Conrad S; Skutella T; van de Lest C; van Weeren R; Stadler PM
    Stem Cell Res Ther; 2017 Jun; 8(1):129. PubMed ID: 28583184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.